Login / Signup

Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection.

Thomas J SandoraLarry K KociolekDavid N WilliamsKaitlyn DaughertyChristine GeerChristine CuddemiXinhua ChenHua XuTimothy J SavageAlice BanzKevin W GareyAnne J Gonzales-LunaCiarán P KellyNira R Pollock
Published in: Infection control and hospital epidemiology (2023)
Higher baseline stool toxin concentrations are present in children with CDI recurrence. Toxin quantification should be included in CDI treatment trials to evaluate its use in severity assessment and outcome prediction.
Keyphrases
  • escherichia coli
  • young adults
  • clostridium difficile
  • free survival
  • replacement therapy